51.8 F
New York
Monday, October 3, 2022

Date:

Share:

Coalition to Cure CHD2 Announces Two Recipients of Its 2022 Early-Stage Investigator Research Grant

Related Articles

Resource Royalty, LLC Announces Bob Howard, Chairman and Beth Good, CEO

Dallas, TX, October 03, 2022 --(PR.com)-- Resource Royalty, a Dallas-based oil and gas royalty portfolio manager since 2010, is pleased to announce changes in senior...

Curvalux and Cambridge Broadband Networks merge to accelerate wireless access technologies

SHEFFIELD, UK – October 3 2022 - A merger between Curvalux UK Ltd and Cambridge Broadband Networks Group (CBNG) was completed today to achieve...
Boise, ID, August 15, 2022 –(PR.com)– Coalition to Cure CHD2 (CCC), a nonprofit organization dedicated to improving the lives of those affected by CHD2-related disorders by funding research necessary for uncovering a cure, announced two recipients of its 2022 early-stage investigator grant. Each grant, both in the amount of $30,000, will help to advance research in CHD2-related neurodevelopmental disorders. Assistant Professor Helen Willsey, PhD, of the University of Southern California San Francisco, and Assistant Professor Moran Rubinstein, PhD, of Tel Aviv University in Israel, are the recipients of the two grant awards.

The awardees were selected through a competitive application process in which written applications were reviewed by the Coalition’s Scientific Advisory Board comprised of scientists and clinicians who have a wide array of backgrounds and expertise in areas relevant to CHD2 research.

The goal of Dr. Helen…

Read more…

Popular Articles